Company Overview
InfraScan Inc. is a medical device company that has developed a patented, Near Infrared (NIR) technology for detecting brain hematomas. The Infrascanner enables clinicians to effectively, conveniently, and accurately screen for intracranial bleeding in patients with head trauma.
December 2011
FDA permits marketing of the first hand-held device to aid in the detection of bleeding in the skull
December 2011
The US Patent Office issued an additional patent for Hematoma Detection
May 2011
Infrascanner Software Designer, Hasan Ayaz, Wins the Design of Medical Devices Top Award
December 2010
The Infrascanner wins its first large tender in Romania
July 2010
CPP SBIR award from the Marine Corps System Command (MCSC)
March 2009
The Infrascanner is featured as a transformational technology in Better World Report.
July 2008
The Infrascanner Model 1000 receives the CE Mark
July 2008
InfraScan’s quality system receives ISO 13845 certification
March 2008
Marines field evaluation in Iraq of Infrascanner Model 1000
February 2008
510k submission to the FDA
June 2007
The Infrascanner Received the Excellence in Design Gold Award
July 2006
Multicenter clinical trials begin
February 2006
Ben Franklin Technology Partners /SEP investment
July 2005
Pre-IDE meeting with the FDA
June 2005
Phase 2 SBIR award from ONR
January 2005
BioAdvance investment
October 2004
2nd place in Global Business Plan Competition in Singapore
April 2004
Winner of Wharton Business Plan Competition
March 2004
Phase 1 SBIR award from the Office of Naval Research (ONR)